lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Targeting of miR-96-5p by Catalpol Ameliorates Oxidative Stress and Hepatic Steatosis in LDLr-/- Mice via p66shc/Cytochrome C Cascade

44 Pages Posted: 15 Jun 2019

See all articles by Yukun Zhang

Yukun Zhang

Dalian University - Department of Clinical Pharmacology

Changyuan Wang

Dalian University - Department of Clinical Pharmacology

Jiawei Lu

Dalian University - Department of Clinical Pharmacology

Yue Jin

Dalian University - Department of Clinical Pharmacology

Canyao Xu

Dalian University - Department of Clinical Pharmacology

Qiang Meng

Dalian University - Department of Clinical Pharmacology

Qi Liu

Dalian University - Department of Clinical Pharmacology

Zhihao Liu

Dalian University - Department of Clinical Pharmacology

Xiaodong Ma

Dalian University - Department of Clinical Pharmacology

Kexin Liu

Dalian University - Department of Clinical Pharmacology

Huijun Sun

Dalian University - Department of Clinical Pharmacology

More...

Abstract

Background: Hepatic steatosis and oxidative stress are considered to sequential steps in the development of non-alcoholic fatty liver disease (NAFLD). We previously found the protective effects of catalpol, an iridoid glucoside extracted from the root of Romania glutinosa L. Here, the increase expression of p66shc was found in NAFLD models and catalpol could inhibit p66shc expression ameliorating NAFLD effectively. Then, we investigated p66shc-targeting miRNAs in regulating oxidative stress and hepatic steatosis, and the potential role of p66shc in NAFLD.

Methods: An NAFLD animal model established by low density lipoprotein receptor knockout (LDLr-/-) mice fed with high fat diet and cellular model by palmitic acid -treated hepG2 cells were employed to investigate the role of catalpol on NAFLD and the underling mechanism miR-96-5p involve in. With histological analysis, western blot, qPCR and transfection assay, identified miR-96-5p as being strongly differentially expressed between NAFLD and normal individuals and catalpol can ameliorate NAFLD via increasing miR-96-5p expression.

Findings: We found that p66Shc, a protein induced by oxidative stress was significantly increased in NAFLD. Results also show that high level of p66shc is correlated with oxidative stress and hepatic steatosis. Moreover, targeting miR-96-5p by catalpol ameliorates oxidative stress and hepatic steatosis in LDLr-/- mice via p66shc/cytochrome C cascade.

Interpretation: These data identify a role for miR-96-5p in NAFLD through inhibiting oxidative stress and hepatic steatosis via p66shc/cytochrome C cascade and the role of catalpol involve in.

Funding Statement: This work was supported by grants from the Chinese National Natural Science Foundation (No.81273508).

Declaration of Interests: The authors declare that they have no conflict of interest.

Ethics Approval Statement: All experiments were approved by the Animal Care and Use Committee of Dalian Medical University, and the experimental procedures were performed in strict accordance with Legislation Regarding the Use and Care of Laboratory Animals of China.

Keywords: MicroRNA; catalpol; NAFLD; oxidative stress; hepatic steatosis

Suggested Citation

Zhang, Yukun and Wang, Changyuan and Lu, Jiawei and Jin, Yue and Xu, Canyao and Meng, Qiang and Liu, Qi and Liu, Zhihao and Ma, Xiaodong and Liu, Kexin and Sun, Huijun, Targeting of miR-96-5p by Catalpol Ameliorates Oxidative Stress and Hepatic Steatosis in LDLr-/- Mice via p66shc/Cytochrome C Cascade (June 13, 2019). Available at SSRN: https://ssrn.com/abstract=3403348 or http://dx.doi.org/10.2139/ssrn.3403348

Yukun Zhang

Dalian University - Department of Clinical Pharmacology

Dalian
China

Changyuan Wang

Dalian University - Department of Clinical Pharmacology

Dalian
China

Jiawei Lu

Dalian University - Department of Clinical Pharmacology

Dalian
China

Yue Jin

Dalian University - Department of Clinical Pharmacology

Dalian
China

Canyao Xu

Dalian University - Department of Clinical Pharmacology

Dalian
China

Qiang Meng

Dalian University - Department of Clinical Pharmacology

Dalian
China

Qi Liu

Dalian University - Department of Clinical Pharmacology

Dalian
China

Zhihao Liu

Dalian University - Department of Clinical Pharmacology

Dalian
China

Xiaodong Ma

Dalian University - Department of Clinical Pharmacology

Dalian
China

Kexin Liu

Dalian University - Department of Clinical Pharmacology

Dalian
China

Huijun Sun (Contact Author)

Dalian University - Department of Clinical Pharmacology ( email )

Dalian
China

Click here to go to TheLancet.com

Paper statistics

Downloads
118
Abstract Views
835
PlumX Metrics